what is safer tirzepatide or semaglutide Troubling Findings in Study of GLP-1 Compounders Tirzepatide and semaglutide, the ingredients

This is risky for several reasons: Wrong patient selection, such as people with pancreatitis, gallstones, or severe kidney disease using them without screening Rapid, unsupervised dose escalation No monitoring of kidney, liver, pancreatic, or eye status Complications seen with unsupervised use include pancreatitis, dehydration-induced acute kidney injury (especially in hot Indian summers with vomiting or diarrhoea), and even diabetic ketoacidosis in susceptible individuals

Suitable with any diet type

Each full dose contains 10 mg of retatrutide, with a total of 40 mg active ingredient in the pen

H.LinehanM.MerinoM